EL
ELI LILLY + CO
LLY· Health Care· PharmaceuticalsS&P 500
Close · 13/11/2026
1,443.50
1D
+1.14%52-week range
850.51 – 1460
Volume
20,81,600.00
Price history
LLY
15/10/2026 to 13/11/2026
O 1,429.91 H 1,449.64 L 1,419.77
1W+6.61%
1M+15.33%
3M+22.00%
6M+43.64%
1Y+41.83%
3Y+133.15%
5Y+444.72%
MAX+506.61%
Fundamentals
as of 13/11/2026- Market cap
- $1.36T
- Shares out
- 940.75M
- P/E (trailing)
- 49.24
- P/E (forward)
- 28.50
- EPS (trailing)
- 29.32
- Dividend yield
- 0.36%
- Beta
- 0.39
- Profit margin
- 31.90%
- P/B
- 33.72
- Return on equity
- 68.48%
SEC financial statements
64 quarterly and 19 annual periods through 30/09/2026.
Details
- Ticker
- LLY
- Index
- SP500
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 13/11/2026.
Tracked by Congress
34 filers · 4 on watchlist · 56 buys · 65 sells · ?: 14 · R: 30 · D: 75 · I: 2
- 20/10/2026Gilbert CisnerosBuyEli Lilly and Company Common Stock$1,001–$15,000
- 21/11/2025John BoozmanWSell+Eli Lilly and Company$1,001–$15,000
- 01/07/2026Michael RulliSellEli Lilly and Company Common Stock$1,001–$15,000
- 02/01/2026Michael RulliBuyEli Lilly and Company Common Stock$1,001–$15,000
- 02/12/2025Michael RulliSellEli Lilly and Company Common Stock$1,001–$15,000
- 15/04/2025Thomas H TubervilleWSellEli Lilly and Company$15,001–$50,000
- 27/03/2026Alan ArmstrongSellEli Lilly and Company Common Stock$1,001–$15,000
- 10/07/2026Dan NewhouseSell+Eli Lilly and Company Common Stock$1,001–$15,000